Arquer Diagnostics’ ADXBLADDER Undergoes U.S. Clinical Trials
ADXBLADDER, a urinary biomarker test for bladder cancer, is currently undergoing clinical trials in the U.S.
Read MorePosted by Chris Wolski | Jul 28, 2021 | Unknown Origin & Other Cancer Types, Urinalysis & Toxicology |
ADXBLADDER, a urinary biomarker test for bladder cancer, is currently undergoing clinical trials in the U.S.
Read MorePosted by Melanie Hamilton-Basich | Jul 27, 2021 | Molecular Diagnostics |
Phosphorus’ GeneCompass test kit uses the latest NGS technology to analyze genes associated with more than 200 health risks and over 200 genetic drug interactions.
Read MorePosted by Melanie Hamilton-Basich | Jul 26, 2021 | Covid 19 |
Medical groups including the AMA are calling on healthcare employers to make COVID-19 vaccination mandatory for those who work for them, reports the New York Times, which could affect those who work at laboratories in healthcare facilities.
Read MorePosted by Chris Wolski | Jul 22, 2021 | Covid 19, Immunoassay Reagents & test Kits, Rapid Assays |
A recent study shows that a new protocol for coronavirus testing can increase clinical labs’ testing capacity without sacrificing accuracy.
Read MorePosted by Melanie Hamilton-Basich | Jul 19, 2021 | Covid 19, Flu & Respiratory Infections |
The cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Read More